45 patents
Page 3 of 3
Utility
Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
23 Dec 21
Disclosed are means, methods, and compositions of matter for prophylaxis and/or treatment of SARS-CoV-2 by administration of dendritic cells in a manner and frequency sufficient to induce activation of innate and/or adaptive immune responses.
Thomas E. Ichim, Timothy G. Dixon, James Veltmeyer
Filed: 22 Jun 20
Utility
Nutraceuticals for Reducing Myeloid Suppressor Cells
16 Dec 21
Disclosed are compositions of matter, treatments and protocols useful for reduction of number and/or activity of myeloid suppressor cells (MSC).
Thomas E. Ichim, Timothy G. Dixon, James Veltmeyer
Filed: 11 Jun 20
Utility
Nutraceuticals for the Prevention, Inhibition, and Treatment of SARS-Cov-2 and Associated COVID-19
4 Nov 21
Disclosed herein are methods of treating or preventing complications associated with a SARS-CoV-2 infection, comprising: administration of a combination comprising: a) Green Tea and/or extract thereof; b) Blueberry and/or extract thereof; c) Nigella sativa and/or extract thereof; and d) broccoli and/or extract thereof in an amount and frequency sufficient to treat or prevent complications associated with said SARS-CoV-2 infection.
Thomas E. Ichim, Timothy G. Dixon
Filed: 4 May 20
Utility
Cellular, Organ, and Whole-body Rejuvenation Utilizing Cord Blood Plasma and Pterostilbene
6 May 21
Disclosed are methods, means, and protocols for stimulation of rejuvenation in single cells, organs, and organisms by administration of cord blood derived plasma, cord blood plasma concentrates, and cord blood derived exosomes together with pterostilbene.
Thomas E. Ichim, Timothy G. Dixon
Filed: 4 Nov 20
Utility
Compositions for regulation and control of appetite
6 Apr 20
Compositions for appetite control and/or regulation or loss of weight are described.
Sue Ann Alter
Filed: 16 Sep 15